No Data
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Perrigo to Get $98 Million From D&O Insurers Over Investor Lawsuit
Express News | Perrigo: Upon Payment Received, to Surrender 2015 & 2016 Policies & Withdraw Claims Related to Securities Litigation Under 2017 & 2018 Policies
Express News | Perrigo Co PLC - Reaches Settlement Agreement With Insurers
Independent Director Jeffrey Kindler Sold A Bunch Of Shares In Perrigo
Insider Sale: Director at $PRGO (PRGO) Sells 17,598 Shares